文献速递临床试验与 GCP流行病学与生物统计

新加坡SingHypertension实用整群随机对照试验:高血压与多重危险因素管理以提升心血管健康的统计分析计划

Statistical analysis plan for management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: the SingHypertension pragmatic cluster randomized controlled trial.
PubMed 文献 · Trials · 2021-01-19

该文介绍SingHypertension整群随机对照试验的统计分析计划,旨在评估多组分干预(MCI)与常规照护对新加坡基层诊所中血压未控制成人降压效果及成本效果。试验纳入1000例≥40岁血压未控制患者,以诊所为单位1:1随机分组,主要终点为24个月收缩压,采用线性混合效应模型重复测量分析。

要点

  • 主要终点为24个月收缩压,采用线性混合效应模型重复测量分析。
  • 以诊所为单位整群随机,8家诊所1:1分配至MCI或常规照护。
  • 预设定并预发表的统计分析计划有助于减少报告偏倚。

核心结论

  • 该试验将评估MCI对血压及心血管危险因素的2年影响,并为卫生规划者提供推广建议。

研究设计与样本

  • 整群随机对照试验,纳入新加坡8家基层诊所的1000例≥40岁血压未控制患者,以诊所为单位1:1随机分配至MCI或常规照护。

关键数值与推荐

  • 主要终点为24个月收缩压,采用基于似然的线性混合效应模型重复测量分析,固定效应为治疗组和随访时间,随机效应为诊所,误差分布为高斯分布,自由度采用Satterthwaite近似调整。
  • 次要结局采用类似的建模方法,并结合适用于结局类型的广义技术进行分析。

临床怎么用

  • 预设定并预发表的统计分析计划可减少报告偏倚和数据驱动方法的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Cardiovascular disease (O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Herrington WG, et al., Am J Kidney Dis 76(1):109-20, 2020) remains the leading cause of death in Singapore. Uncontrolled hypertension confers the highest attributable risk of CVD and remains a significant public health issue with sub-optimal blood pressure (BP) control rates. The aim of the trial is to evaluate the effectiveness and cost-effectiveness of a multicomponent intervention (MCI) versus usual care on lowering BP among adults with uncontrolled hypertension visiting primary care clinics in Singapore. This article describes the statistical analysis plan for the primary and secondary objectives related to intervention effectiveness. METHODS: The study is a cluster randomized trial enrolling 1000 participants with uncontrolled hypertension aged ≥ 40 years from eight primary care clinics in Singapore. The unit of randomization is the clinic, with eight clusters (clinics) randomized in a 1:1 ratio to either MCI or usual care. All participants will be assessed at baseline, 12 months, and 24 months with measurements of systolic and diastolic BP, antihypertensive and statin medication use, medication adherence, physical activity level, anthropometric parameters, smoking status, and dietary habits. The primary objective of this study is to assess the effectiveness of MCI versus usual care on mean SBP at the 2-year follow-up. The primary outcome is SBP at 24 months. SBP at baseline, 12, and 24 months will be modeled at the subject level using a likelihood-based, linear mixed-effects model repeated measures (MMRM) analysis with treatment group and follow-up as fixed effects, random cluster (clinic) effects, Gaussian error distribution, and adjustment to degrees of freedom using the Satterthwaite approximation. Secondary outcomes will be analyzed using a similar modeling approach incorporating generalized techniques appropriate for the type of outcome. DISCUSSION: The trial will allow us to determine whether the MCI has an impact on BP and cardiovascular risk factors over a 2-year follow-up period and inform recommendations for health planners in scaling up these strategies for the benefit of society at large. A pre-specified and pre-published statistical analysis plan mitigates reporting bias and data driven approaches. TRIAL REGISTRATION: ClinicalTrials.gov NCT02972619 . Registered on 23 November 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Allen JC, Halaand B, Shirore RM, et al. Statistical analysis plan for management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: the SingHypertension pragmatic cluster randomized controlled trial. Trials. 2021. PMID: 33468225. doi:10.1186/s13063-020-05016-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。